171 related articles for article (PubMed ID: 35802605)
1. Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions.
Buehler M; Yi X; Ge W; Blattmann P; Rushing E; Reifenberger G; Felsberg J; Yeh C; Corn JE; Regli L; Zhang J; Cloos A; Ravi VM; Wiestler B; Heiland DH; Aebersold R; Weller M; Guo T; Weiss T
Neuro Oncol; 2023 Feb; 25(2):290-302. PubMed ID: 35802605
[TBL] [Abstract][Full Text] [Related]
2. An advanced glioma cell invasion assay based on organotypic brain slice cultures.
Eisemann T; Costa B; Strelau J; Mittelbronn M; Angel P; Peterziel H
BMC Cancer; 2018 Jan; 18(1):103. PubMed ID: 29378533
[TBL] [Abstract][Full Text] [Related]
3. Loss of F-box only protein 2 (Fbxo2) disrupts levels and localization of select NMDA receptor subunits, and promotes aberrant synaptic connectivity.
Atkin G; Moore S; Lu Y; Nelson RF; Tipper N; Rajpal G; Hunt J; Tennant W; Hell JW; Murphy GG; Paulson H
J Neurosci; 2015 Apr; 35(15):6165-78. PubMed ID: 25878288
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.
Shankavaram UT; Bredel M; Burgan WE; Carter D; Tofilon P; Camphausen K
J Cell Mol Med; 2012 Mar; 16(3):545-54. PubMed ID: 21595825
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment.
Kalita-de Croft P; Straube J; Lim M; Al-Ejeh F; Lakhani SR; Saunus JM
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31121957
[TBL] [Abstract][Full Text] [Related]
7. Multiple formin proteins participate in glioblastoma migration.
Heuser VD; Kiviniemi A; Lehtinen L; Munthe S; Kristensen BW; Posti JP; Sipilä JOT; Vuorinen V; Carpén O; Gardberg M
BMC Cancer; 2020 Jul; 20(1):710. PubMed ID: 32727404
[TBL] [Abstract][Full Text] [Related]
8. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
[TBL] [Abstract][Full Text] [Related]
9. Fbxo2 mediates clearance of damaged lysosomes and modifies neurodegeneration in the Niemann-Pick C brain.
Liu EA; Schultz ML; Mochida C; Chung C; Paulson HL; Lieberman AP
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32931479
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
11. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
12. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
[TBL] [Abstract][Full Text] [Related]
13. Proteomic level changes associated with S3I201 treated U87 glioma cells.
Jain R; Atak A; Yeola A; Srivastava S
J Proteomics; 2017 Jan; 150():341-350. PubMed ID: 27565396
[TBL] [Abstract][Full Text] [Related]
14. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
Jensen SS; Petterson SA; Halle B; Aaberg-Jessen C; Kristensen BW
BMC Cancer; 2017 Mar; 17(1):178. PubMed ID: 28270132
[TBL] [Abstract][Full Text] [Related]
15. FBXO2, a novel marker for metastasis in human gastric cancer.
Sun X; Wang T; Guan ZR; Zhang C; Chen Y; Jin J; Hua D
Biochem Biophys Res Commun; 2018 Jan; 495(3):2158-2164. PubMed ID: 29269301
[TBL] [Abstract][Full Text] [Related]
16. Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis.
Yang Y; Gao X; Zhang M; Yan S; Sun C; Xiao F; Huang N; Yang X; Zhao K; Zhou H; Huang S; Xie B; Zhang N
J Natl Cancer Inst; 2018 Mar; 110(3):304-15. PubMed ID: 28903484
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of scRNA-seq and bulk RNA-seq identifies
Lai W; Xie R; Chen C; Lou W; Yang H; Deng L; Lu Q; Tang X
Heliyon; 2024 Apr; 10(7):e28490. PubMed ID: 38590858
[TBL] [Abstract][Full Text] [Related]
18. An allograft glioma model reveals the dependence of aquaporin-4 expression on the brain microenvironment.
Noell S; Ritz R; Wolburg-Buchholz K; Wolburg H; Fallier-Becker P
PLoS One; 2012; 7(5):e36555. PubMed ID: 22590566
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional dendritic cells limit antigen-specific T cell response in glioma.
Friedrich M; Hahn M; Michel J; Sankowski R; Kilian M; Kehl N; Günter M; Bunse T; Pusch S; von Deimling A; Wick W; Autenrieth SE; Prinz M; Platten M; Bunse L
Neuro Oncol; 2023 Feb; 25(2):263-276. PubMed ID: 35609569
[TBL] [Abstract][Full Text] [Related]
20. ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.
Chong YK; Sandanaraj E; Koh LW; Thangaveloo M; Tan MS; Koh GR; Toh TB; Lim GG; Holbrook JD; Kon OL; Nadarajah M; Ng I; Ng WH; Tan NS; Lim KL; Tang C; Ang BT
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
